Literature DB >> 15504945

Effect of an increase in C-reactive protein level during a hemodialysis session on mortality.

Johanna C Korevaar1, Jeannette G van Manen, Friedo W Dekker, Dirk R de Waart, Elisabeth W Boeschoten, Raymond T Krediet.   

Abstract

The prevalence of chronic inflammation is high in dialysis patients. Moreover, it is associated with an increased mortality risk, yet the origin of chronic inflammation in dialysis patients remains unclear. The aim of this study was to determine the effect of a hemodialysis session (HD) on C-reactive protein (CRP) levels and to study the relation with survival. As part of a large, prospective, multicenter study in the Netherlands (Netherlands Cooperative Study on the Adequacy of Dialysis), patients who were started on dialysis treatment between September 1997 and May 1999 were included. Demographic data, clinical data, and serum samples were collected at regularly timed intervals. From this cohort, a random sample of patients was taken. CRP levels were determined before and after an HD session and before the next session. Date of death or censoring was recorded until September 2002. A total of 186 HD patients were included. Mean age was 65 yr (SD, 13); 56% were male. A total of 71 patients had a CRP level below the detection limit (3 mg/L), 68 patients showed no increase in CRP during an HD session (no-increase group), and 47 (25%) patients showed an increase in CRP level during an HD session (increase-group). No statistically difference in mean CRP levels before the dialysis session was found between the increase group (22.3 mg/L) and the no-increase group (19.4 mg/L). In the subsequent interdialytic period, CRP levels returned to the levels of the initial CRP value. Two-year survival was 44% in the increase group and 66% in the no-increase group (P = 0.09). Independent of CRP level before the session and adjusted for age, comorbidity, nutritional status, and primary kidney disease, a raise of 1 mg/L CRP during a session was associated with a 9% increased mortality risk (adjusted hazard ratio, 1.09; 95% CI, 1.02 to 1.16). The present study showed an increase in CRP level during a single dialysis session in 25% of the patients; during the succeeding interdialytic period, CRP level returned to its original value. More important, however, an increase in CRP level during an HD session was independently associated with a higher mortality risk.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15504945     DOI: 10.1097/01.ASN.0000143744.72664.66

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  21 in total

Review 1.  Monitoring of inflammation in patients on dialysis: forewarned is forearmed.

Authors:  Christiaan L Meuwese; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2011-03       Impact factor: 28.314

2.  Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1.

Authors:  Chih-Ching Lin; Xiao-Ming Liu; Kelly Peyton; Hong Wang; Wu-Chang Yang; Shing-Jong Lin; William Durante
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-17       Impact factor: 8.311

3.  High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis.

Authors:  Daniela Lemos Borges; Helton Pereira Lemes; Valéria de Castro Ferreira; Sebastião Rodrigues Ferreira Filho
Journal:  Clin Exp Nephrol       Date:  2016-01-14       Impact factor: 2.801

4.  The contact activation inhibitor AB023 in heparin-free hemodialysis: results of a randomized phase 2 clinical trial.

Authors:  Christina U Lorentz; Erik I Tucker; Norah G Verbout; Joseph J Shatzel; Sven R Olson; Brandon D Markway; Michael Wallisch; Martina Ralle; Monica T Hinds; Owen J T McCarty; David Gailani; Jeffrey I Weitz; András Gruber
Journal:  Blood       Date:  2021-12-02       Impact factor: 22.113

5.  Effect of inflammation on the relationship of pulse pressure and mortality in haemodialysis.

Authors:  Debasish Banerjee; Allan J Collins; Charles A Herzog
Journal:  Nephron Extra       Date:  2012-01-18

6.  The initial vascular access type contributes to inflammation in incident hemodialysis patients.

Authors:  Mala Sachdeva; Adriana Hung; Oleksandr Kovalchuk; Markus Bitzer; Michele H Mokrzycki
Journal:  Int J Nephrol       Date:  2011-10-25

7.  Acute Effects of Hemodiafiltration Versus Conventional Hemodialysis on Endothelial Function and Inflammation: A Randomized Crossover Study.

Authors:  Ping Jia; Wei Jin; Jie Teng; Hao Zhang; Jianzhou Zou; Zhonghua Liu; Bo Shen; Xuesen Cao; Xiaoqiang Ding
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

8.  The Effect of the Hydroalcoholic Extract of Watercress on the Levels of Protein Carbonyl, Inflammatory Markers, and Vitamin E in Chronic Hemodialysis Patients.

Authors:  Moslem Sedaghattalab; Marzieh Razazan; Mohsen Shahpari; Nahid Azarmehr; Rozina Abbasi Larki; Hossein Sadeghi; Arash Asfaram; Tahere Taheri; Aminollah Pourshohod; Zahra Moslemi; Kazem Abbaszadeh-Goudarzi; Amir Hossein Doustimotlagh
Journal:  Biochem Res Int       Date:  2021-05-26

9.  Effect of hyperinsulinemia during hemodialysis on the insulin-like growth factor system and inflammatory biomarkers: a randomized open-label crossover study.

Authors:  Mark Reinhard; Jan Frystyk; Bente Jespersen; Mette Bjerre; Jens S Christiansen; Allan Flyvbjerg; Per Ivarsen
Journal:  BMC Nephrol       Date:  2013-04-04       Impact factor: 2.388

10.  Membrane Bioincompatibility and Ultrafiltration Effects on Pulse Wave Analysis during Haemodialysis.

Authors:  Maria-Pau Valenzuela; Jaume Almirall; María-José Amengual
Journal:  ISRN Nephrol       Date:  2012-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.